1.5300
+0.3800
+(33.04%)
At close: April 9 at 4:00:03 PM EDT
1.5297
-0.00
(-0.02%)
Pre-Market: 8:22:20 AM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
137,872
128,223
204,302
286,533
Total Liabilities Net Minority Interest
190,541
114,677
87,374
164,359
Total Equity Gross Minority Interest
-52,669
13,546
116,928
122,174
Total Capitalization
-52,669
13,546
137,264
149,535
Common Stock Equity
-52,669
13,546
116,928
122,174
Capital Lease Obligations
16,537
18,906
21,159
23,817
Net Tangible Assets
-52,669
13,546
116,928
122,174
Working Capital
27,905
64,835
134,628
218,290
Invested Capital
-52,669
13,546
145,835
149,535
Tangible Book Value
-52,669
13,546
116,928
122,174
Total Debt
16,537
18,906
50,066
51,178
Share Issued
130,027.5090
103,673.7280
103,229.0130
103,003.6460
Ordinary Shares Number
130,027.5090
103,673.7280
103,229.0130
103,003.6460
12/31/2021 - 12/1/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALDX Aldeyra Therapeutics, Inc.
1.9400
+1.04%
HEPA Hepion Pharmaceuticals, Inc.
0.4878
+18.98%
PHIO Phio Pharmaceuticals Corp.
1.5400
+52.48%
SGMO Sangamo Therapeutics, Inc.
0.6987
+11.29%
BDRX Biodexa Pharmaceuticals Plc
1.5100
+7.09%
OSRH OSR Holdings, Inc.
1.5300
+2.00%
ZVSA ZyVersa Therapeutics, Inc.
1.0300
-18.90%
SANA Sana Biotechnology, Inc.
1.5500
+15.67%
IBO Impact BioMedical Inc.
0.5184
-20.25%
LXRX Lexicon Pharmaceuticals, Inc.
0.4909
-2.04%